Phathom Pharmaceuticals, Inc. Banner Image

Phathom Pharmaceuticals, Inc. has reached its limit for free report views

Work for Phathom Pharmaceuticals, Inc.? Upgrade Your Profile and unlock all your annual reports.

Upgrade Profile

Phathom Pharmaceuticals, Inc.

Ticker PHAT

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

11-50 Employees
Based in Florham Park, New Jersey

Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. Phathom has in-licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a novel potassium competitive acid blocker (P-CAB) in late-stage development for the treatment of acid-related disorders.

Visit website

REPORT RATINGS

4.8 / 5.0 (148)

Phathom Pharmaceuticals, Inc. reports have an aggregate usefulness score of 4.8 based on 148 reviews.

Phathom Pharmaceuticals, Inc.